NUCCIO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 187
AS - Asia 171
NA - Nord America 95
SA - Sud America 9
AF - Africa 3
Totale 465
Nazione #
RU - Federazione Russa 95
US - Stati Uniti d'America 90
SG - Singapore 75
IT - Italia 56
VN - Vietnam 38
CN - Cina 25
HK - Hong Kong 19
GB - Regno Unito 10
BR - Brasile 5
DE - Germania 5
NL - Olanda 5
FI - Finlandia 3
FR - Francia 3
IN - India 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
CA - Canada 2
ES - Italia 2
JP - Giappone 2
MX - Messico 2
ZA - Sudafrica 2
AR - Argentina 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 465
Città #
Singapore 53
Hong Kong 19
Ho Chi Minh City 18
Dallas 17
Ashburn 15
Rome 11
Milan 10
Moscow 8
Beijing 7
Cesano Boscone 7
San Jose 7
Hanoi 6
Boardman 5
New York 5
Rotherham 5
Da Nang 4
Hefei 4
Los Angeles 4
Naples 4
Iesi 3
Lauterbourg 3
Orem 3
Amsterdam 2
Boston 2
Denver 2
Florence 2
Hyderabad 2
Johannesburg 2
Lappeenranta 2
Long Xuyen 2
Manchester 2
Meda 2
Nuremberg 2
Parma 2
Santa Clara 2
Shanghai 2
São Paulo 2
The Dalles 2
Tokyo 2
Anyang 1
Baghdad 1
Barnet 1
Brussels 1
Catania 1
Centenario 1
Chicago 1
City of London 1
Cleveland 1
Cochabamba 1
Evanston 1
Falkenstein 1
Guarulhos 1
Guayaquil 1
Guiyang 1
Helsinki 1
Hải Dương 1
Imus 1
Kuala Lumpur 1
Madrid 1
Managua 1
Mexico City 1
Montreal 1
Multan 1
Munich 1
New Delhi 1
Nicosia 1
Norfolk 1
Oroville 1
Ospitaletto 1
Phú Nhuận 1
Poplar 1
Quanzhou 1
Querétaro 1
Quận Ba 1
Rho 1
Romagnano Sesia 1
Shadrinsk 1
Sorocaba 1
Stockholm 1
São José dos Campos 1
Tam Kỳ 1
The Hague 1
Treviso 1
Tunis 1
Vancouver 1
Warsaw 1
Washington 1
Zurich 1
Totale 301
Nome #
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience 182
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC 104
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies 95
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? 88
A viable human lung cancer tissue collection (LCTC) to accelerate translational research 5
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis 3
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: A reconstructed individual patient data meta-analysis 3
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis 2
Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas 2
Totale 484
Categoria #
all - tutte 1.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 1 2 1 3 1 0 4
2024/2025129 12 4 0 4 7 2 10 24 13 42 3 8
2025/2026343 18 18 10 37 45 14 37 39 101 24 0 0
Totale 484